Lifeint and Zhongshan Hospital of Xiamen University published research on early gastric cancer diagnosis in Molecular Cancer. The original company announcement listed an impact factor of 6.204 at the time and named Xiamen LifeInt Technology Co., Ltd. as an author affiliation.

Read the original article: https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-018-0834-9